Siru Mäkelä

1.6k total citations
27 papers, 653 citations indexed

About

Siru Mäkelä is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Siru Mäkelä has authored 27 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 11 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Siru Mäkelä's work include Cancer Immunotherapy and Biomarkers (11 papers), Immunotherapy and Immune Responses (8 papers) and CAR-T cell therapy research (7 papers). Siru Mäkelä is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Immunotherapy and Immune Responses (8 papers) and CAR-T cell therapy research (7 papers). Siru Mäkelä collaborates with scholars based in Finland, Sweden and United States. Siru Mäkelä's co-authors include Juha Kere, Christer Holmberg, Pia Höglund, Hannes Lohi, Eero Lehtonen, Ulpu Saarialho‐Kere, Marjo Kestilä, Daniel Markovich, Minna Kujala and Satu Wedenoja and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Siru Mäkelä

26 papers receiving 636 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Siru Mäkelä Finland 11 342 173 166 139 111 27 653
Efren Rael United States 7 340 1.0× 77 0.4× 99 0.6× 102 0.7× 78 0.7× 19 677
Thierry Gilbert France 15 546 1.6× 130 0.8× 47 0.3× 92 0.7× 66 0.6× 17 873
Sydney M. Escobar United States 10 251 0.7× 46 0.3× 108 0.7× 99 0.7× 274 2.5× 12 764
Gail Coghlan Canada 15 316 0.9× 48 0.3× 60 0.4× 130 0.9× 60 0.5× 60 896
J. Richard Brewer United States 7 548 1.6× 51 0.3× 48 0.3× 67 0.5× 88 0.8× 7 718
Margaret M. McDaniel United States 11 330 1.0× 45 0.3× 67 0.4× 66 0.5× 233 2.1× 15 650
Jie Pan China 17 194 0.6× 116 0.7× 142 0.9× 144 1.0× 84 0.8× 51 652
Jean‐Philippe Babeu Canada 11 304 0.9× 26 0.2× 152 0.9× 217 1.6× 77 0.7× 13 588
Tapati Maity United States 9 561 1.6× 192 1.1× 127 0.8× 97 0.7× 68 0.6× 14 775
Wanna Thongnoppakhun Thailand 17 382 1.1× 63 0.4× 55 0.3× 24 0.2× 63 0.6× 51 812

Countries citing papers authored by Siru Mäkelä

Since Specialization
Citations

This map shows the geographic impact of Siru Mäkelä's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siru Mäkelä with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siru Mäkelä more than expected).

Fields of papers citing papers by Siru Mäkelä

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siru Mäkelä. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siru Mäkelä. The network helps show where Siru Mäkelä may publish in the future.

Co-authorship network of co-authors of Siru Mäkelä

This figure shows the co-authorship network connecting the top 25 collaborators of Siru Mäkelä. A scholar is included among the top collaborators of Siru Mäkelä based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siru Mäkelä. Siru Mäkelä is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kytölä, Soili, Erdoğan Pekcan Erkan, Maarit Ahtiainen, et al.. (2025). Performance Comparison of Droplet Digital PCR and Next‐Generation Sequencing for Circulating Tumor DNA Detection in Non‐Metastatic Rectal Cancer. Cancer Medicine. 14(9). e70943–e70943. 2 indexed citations
2.
3.
Leivonen, Suvi‐Katri, et al.. (2023). Intra-patient evolution of tumor microenvironment in the pathogenesis of treatment-naïve metastatic melanoma patients. Acta Oncologica. 62(9). 1008–1013. 1 indexed citations
4.
Huuhtanen, Jani, Katriina Peltola, Tapio Lönnberg, et al.. (2023). Single-cell characterization of anti–LAG-3 and anti–PD-1 combination treatment in patients with melanoma. Journal of Clinical Investigation. 133(6). 60 indexed citations
5.
Vahlberg, Tero, et al.. (2023). The effect of nurse-led empowering education on nutrition impact side effects in patients with colorectal cancer undergoing chemotherapy: A randomised trial. Patient Education and Counseling. 115. 107895–107895. 2 indexed citations
6.
Mattila, Kalle, Siru Mäkelä, Soili Kytölä, et al.. (2022). Circulating tumor DNA is a prognostic biomarker in metastatic melanoma patients treated with chemoimmunotherapy and BRAF inhibitor. Acta Oncologica. 61(10). 1263–1267. 4 indexed citations
7.
Chiaro, Jacopo, Thomas Whalley, Cristian Capasso, et al.. (2021). Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma. Cancer Immunology Research. 9(8). 981–993. 25 indexed citations
8.
Ritmala‐Castrén, Marita, et al.. (2021). Empowering patient education on self-care activity among patients with colorectal cancer – a research protocol for a randomised trial. BMC Nursing. 20(1). 94–94. 7 indexed citations
9.
Arjama, Mariliina, Siru Mäkelä, Katja Välimäki, et al.. (2021). High-throughput ex vivo drug testing identifies potential drugs and drug combinations for NRAS-positive malignant melanoma. Translational Oncology. 15(1). 101290–101290. 4 indexed citations
10.
Mäkelä, Siru, Anders Albäck, Pirkka Vikatmaa, et al.. (2021). Isolated limb perfusion with melphalan as treatment for regionally advanced melanoma of the limbs: results of 60 patients treated in Finland during 2007–2018. Melanoma Research. 31(5). 456–463. 1 indexed citations
11.
Hernberg, Micaela, Siru Mäkelä, Oscar Brück, et al.. (2020). Age-associated changes in the immune system may influence the response to anti-PD1 therapy in metastatic melanoma patients. Cancer Immunology Immunotherapy. 69(5). 717–730. 16 indexed citations
12.
Hernberg, Micaela, Siru Mäkelä, Bhagwan Yadav, et al.. (2019). Abstract A130: Metastatic melanoma patients responding to PD1 therapy have higher proportion of peripheral blood NKT-cells. Cancer Immunology Research. 7(2_Supplement). A130–A130. 3 indexed citations
13.
Ryhänen, Eeva, Frank V. Bensch, Ilkka Heiskanen, et al.. (2018). Recurrent Metastasized Parathyroid Carcinoma—Long‐Term Remission After Combined Treatments With Surgery, Radiotherapy, Cinacalcet, Zoledronic Acid, and Temozolomide. JBMR Plus. 3(4). e10114–e10114. 16 indexed citations
14.
Jansen, Yanina, Elisa A. Rozeman, Marnix Geukes Foppen, et al.. (2017). Real life outcome of advanced melanoma patients who discontinue pembrolizumab (PEMBRO) in the absence of disease progression.. Journal of Clinical Oncology. 35(15_suppl). 9539–9539. 6 indexed citations
15.
Wedenoja, Satu, et al.. (2011). Update on SLC26A3 mutations in congenital chloride diarrhea. Human Mutation. 32(7). 715–722. 88 indexed citations
16.
Rautanen, Anna, Marco Zucchelli, Siru Mäkelä, & Juha Kere. (2005). Gene mapping with pooled samples on three genotyping platforms. Molecular and Cellular Probes. 19(6). 408–416. 5 indexed citations
17.
Mäkelä, Siru, et al.. (2004). Mutational analysis of the human SLC26A8 gene: exclusion as a candidate for male infertility due to primary spermatogenic failure. Molecular Human Reproduction. 11(2). 129–132. 18 indexed citations
18.
Mäkelä, Siru, Juha Kere, Christer Holmberg, & Pia Höglund. (2002). SLC26A3 mutations in congenital chloride diarrhea. Human Mutation. 20(6). 425–438. 114 indexed citations
19.
Lohi, Hannes, Minna Kujala, Siru Mäkelä, et al.. (2002). Functional Characterization of Three Novel Tissue-specific Anion Exchangers SLC26A7, -A8, and -A9. Journal of Biological Chemistry. 277(16). 14246–14254. 182 indexed citations
20.
Lohi, Hannes, Siru Mäkelä, Peter Höglund, et al.. (2002). Upregulation of CFTR expression but not SLC26A3 and SLC9A3 in ulcerative colitis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 283(3). G567–G575. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Efren Rael Breakdown of academic impact, for papers by Thierry Gilbert Breakdown of academic impact, for papers by Sydney M. Escobar Breakdown of academic impact, for papers by Gail Coghlan Breakdown of academic impact, for papers by J. Richard Brewer Breakdown of academic impact, for papers by Margaret M. McDaniel Breakdown of academic impact, for papers by Jie Pan Breakdown of academic impact, for papers by Jean‐Philippe Babeu Breakdown of academic impact, for papers by Tapati Maity Breakdown of academic impact, for papers by Wanna Thongnoppakhun
Rankless by CCL
2026